1. INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. RESEARCH METHODOLOGY 1.2.1 SECONDARY RESEARCH 1.2.2 DATA ANALYSIS FRAMEWORK 1.2.3 MARKET SIZE ESTIMATION 1.2.4 FORECASTING 1.2.5 PRIMARY RESEARCH AND DATA VALIDATION 2. MARKET SNAPSHOT, 2019-2030 MILLION USD 2.1. MARKET SNAPSHOT 3. PORTER’S FIVE FORCE MODEL ANALYSIS 4. MARKET DYNAMICS 4.1. GROWTH DRIVERS 4.1.1 DRIVER 1 4.1.2 DRIVER 2 4.1.3 DRIVER 3 4.1.4 DRIVER 4 4.2. CHALLENGES 4.2.1 CHALLENGE 1 4.2.2 CHALLENGE 2 4.3. OPPORTUNITIES 4.3.1 OPPORTUNITY 1 4.3.2 OPPORTUNITY 2 5. GLOBAL MIGRAINE DRUGS MARKET, BY TYPE 5.1. OVERVIEW 5.2. ABORTIVE MEDICINES 5.2.1 GLOBAL ABORTIVE MEDICINES MARKET, BY TYPE 5.2.1.1 Triptans Market, By Region 5.2.1.1.1 North America Triptans Market, By Country 5.2.1.1.2 Europe Triptans Market, By Country 5.2.1.1.3 Asia-Pacific Triptans Market, By Country 5.2.1.1.4 Rest of World Triptans Market, By Country 5.2.1.2 Ergotamine Derivatives Market, By Region 5.2.1.2.1 North America Ergotamine Derivatives Market, By Country 5.2.1.2.2 Europe Ergotamine Derivatives Market, By Country 5.2.1.2.3 Asia-Pacific Ergotamine Derivatives Market, By Country 5.2.1.2.4 Rest of World Ergotamine Derivatives Market, By Country 5.2.1.3 Other Abortive Medicine Market, By Region 5.2.1.3.1 North America Other Abortive Medicine Market, By Country 5.2.1.3.2 Europe Other Abortive Medicine Market, By Country 5.2.1.3.3 Asia-Pacific Other Abortive Medicine Market, By Country 5.2.1.3.4 Rest of World Other Abortive Medicine Market, By Country 5.2.2 ABORTIVE MEDICINES MARKET, BY REGION 5.2.2.1 North America Abortive Medicines Market, By Country 5.2.2.2 Europe Abortive Medicines Market, By Country 5.2.2.3 Asia-Pacific Abortive Medicines Market, By Country 5.2.2.4 Rest of World Abortive Medicines Market, By Country 5.3. PREVENTIVE MEDICINES 5.3.1 GLOBAL PREVENTIVE MEDICINES MARKET, BY TYPE 5.3.1.1 Anticonvulsants Market, By Region 5.3.1.1.1 North America Anticonvulsants Market, By Country 5.3.1.1.2 Europe Anticonvulsants Market, By Country 5.3.1.1.3 Asia-Pacific Anticonvulsants Market, By Country 5.3.1.1.4 Rest of World Anticonvulsants Market, By Country 5.3.1.2 Antidepressants Market, By Region 5.3.1.2.1 North America Antidepressants Market, By Country 5.3.1.2.2 Europe Antidepressants Market, By Country 5.3.1.2.3 Asia-Pacific Antidepressants Market, By Country 5.3.1.2.4 Rest of World Antidepressants Market, By Country 5.3.1.3 Beta Blockers Market, By Region 5.3.1.3.1 North America Beta Blockers Market, By Country 5.3.1.3.2 Europe Beta Blockers Market, By Country 5.3.1.3.3 Asia-Pacific Beta Blockers Market, By Country 5.3.1.3.4 Rest of World Beta Blockers Market, By Country 5.3.1.4 Other Preventive Medicines Market, By Region 5.3.1.4.1 North America Other Preventive Medicines Market, By Country 5.3.1.4.2 Europe Other Preventive Medicines Market, By Country 5.3.1.4.3 Asia-Pacific Other Preventive Medicines Market, By Country 5.3.1.4.4 Rest of World Other Preventive Medicines Market, By Country 5.3.2 PREVENTIVE MEDICINES MARKET, BY REGION 5.3.2.1 North America Preventive Medicines Market, By Country 5.3.2.2 Europe Preventive Medicines Market, By Country 5.3.2.3 Asia-Pacific Preventive Medicines Market, By Country 5.3.2.4 Rest of World Preventive Medicines Market, By Country 6. GLOBAL MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION 6.1. OVERVIEW 6.2. ORAL 6.2.1 ORAL MARKET, BY REGION 6.2.1.1 North America Oral Market, By Country 6.2.1.2 Europe Oral Market, By Country 6.2.1.3 Asia-Pacific Oral Market, By Country 6.2.1.4 Rest of World Oral Market, By Country 6.3. INJECTION 6.3.1 INJECTION MARKET, BY REGION 6.3.1.1 North America Injection Market, By Country 6.3.1.2 Europe Injection Market, By Country 6.3.1.3 Asia-Pacific Injection Market, By Country 6.3.1.4 Rest of World Injection Market, By Country 6.4. OTHER ROUTES 6.4.1 OTHER ROUTES MARKET, BY REGION 6.4.1.1 North America Other Routes Market, By Country 6.4.1.2 Europe Other Routes Market, By Country 6.4.1.3 Asia-Pacific Other Routes Market, By Country 6.4.1.4 Rest of World Other Routes Market, By Country 7. GLOBAL MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL 7.1. OVERVIEW 7.2. RETAIL PHARMACIES 7.2.1 RETAIL PHARMACIES MARKET, BY REGION 7.2.1.1 North America Retail Pharmacies Market, By Country 7.2.1.2 Europe Retail Pharmacies Market, By Country 7.2.1.3 Asia-Pacific Retail Pharmacies Market, By Country 7.2.1.4 Rest of World Retail Pharmacies Market, By Country 7.3. HOSPITAL PHARMACIES 7.3.1 HOSPITAL PHARMACIES MARKET, BY REGION 7.3.1.1 North America Hospital Pharmacies Market, By Country 7.3.1.2 Europe Hospital Pharmacies Market, By Country 7.3.1.3 Asia-Pacific Hospital Pharmacies Market, By Country 7.3.1.4 Rest of World Hospital Pharmacies Market, By Country 7.4. ONLINE PHARMACIES 7.4.1 ONLINE PHARMACIES MARKET, BY REGION 7.4.1.1 North America Online Pharmacies Market, By Country 7.4.1.2 Europe Online Pharmacies Market, By Country 7.4.1.3 Asia-Pacific Online Pharmacies Market, By Country 7.4.1.4 Rest of World Online Pharmacies Market, By Country 8. GLOBAL MIGRAINE DRUGS MARKET, BY REGION 8.1. OVERVIEW 8.2. NORTH AMERICA 8.2.1 NORTH AMERICA MIGRAINE DRUGS MARKET, BY TYPE 8.2.1.1 North America Abortive Medicines Market, By Type 8.2.1.2 North America Preventive Medicines Market, By Type 8.2.2 NORTH AMERICA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION 8.2.3 NORTH AMERICA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL 8.2.4 NORTH AMERICA MIGRAINE DRUGS, MARKET BY COUNTRY 8.2.4.1 U.S. 8.2.4.1.1 U.S. Migraine Drugs Market, By Type 8.2.4.1.1.1. U.S. Abortive Medicines Market, By Type 8.2.4.1.1.2. U.S. Preventive Medicines Market, By Type 8.2.4.1.2 U.S. Migraine Drugs Market, By Route of Administration 8.2.4.1.3 U.S. Migraine Drugs Market, By Distribution Channel 8.2.4.2 Canada 8.2.4.2.1 Canada Migraine Drugs Market, By Type 8.2.4.2.1.1. Canada Abortive Medicines Market, By Type 8.2.4.2.1.2. Canada Preventive Medicines Market, By Type 8.2.4.2.2 Canada Migraine Drugs Market, By Route of Administration 8.2.4.2.3 Canada Migraine Drugs Market, By Distribution Channel 8.2.4.3 Mexico 8.2.4.3.1 Mexico Migraine Drugs Market, By Type 8.2.4.3.1.1. Mexico Abortive Medicines Market, By Type 8.2.4.3.1.2. Mexico Preventive Medicines Market, By Type 8.2.4.3.2 Mexico Migraine Drugs Market, By Route of Administration 8.2.4.3.3 Mexico Migraine Drugs Market, By Distribution Channel 8.3. EUROPE 8.3.1 EUROPE MIGRAINE DRUGS MARKET, BY TYPE 8.3.1.1 Europe Abortive Medicines Market, By Type 8.3.1.2 Europe Preventive Medicines Market, By Type 8.3.2 EUROPE MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION 8.3.3 EUROPE MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL 8.3.4 EUROPE MIGRAINE DRUGS, MARKET BY COUNTRY 8.3.4.1 Germany 8.3.4.1.1 Germany Migraine Drugs Market, By Type 8.3.4.1.1.1. Germany Abortive Medicines Market, By Type 8.3.4.1.1.2. Germany Preventive Medicines Market, By Type 8.3.4.1.2 Germany Migraine Drugs Market, By Route of Administration 8.3.4.1.3 Germany Migraine Drugs Market, By Distribution Channel 8.3.4.2 UK 8.3.4.2.1 UK Migraine Drugs Market, By Type 8.3.4.2.1.1. UK Abortive Medicines Market, By Type 8.3.4.2.1.2. UK Preventive Medicines Market, By Type 8.3.4.2.2 UK Migraine Drugs Market, By Route of Administration 8.3.4.2.3 UK Migraine Drugs Market, By Distribution Channel 8.3.4.3 France 8.3.4.3.1 France Migraine Drugs Market, By Type 8.3.4.3.1.1. France Abortive Medicines Market, By Type 8.3.4.3.1.2. France Preventive Medicines Market, By Type 8.3.4.3.2 France Migraine Drugs Market, By Route of Administration 8.3.4.3.3 France Migraine Drugs Market, By Distribution Channel 8.3.4.4 Italy 8.3.4.4.1 Italy Migraine Drugs Market, By Type 8.3.4.4.1.1. Italy Abortive Medicines Market, By Type 8.3.4.4.1.2. Italy Preventive Medicines Market, By Type 8.3.4.4.2 Italy Migraine Drugs Market, By Route of Administration 8.3.4.4.3 Italy Migraine Drugs Market, By Distribution Channel 8.3.4.5 Spain 8.3.4.5.1 Spain Migraine Drugs Market, By Type 8.3.4.5.1.1. Spain Abortive Medicines Market, By Type 8.3.4.5.1.2. Spain Preventive Medicines Market, By Type 8.3.4.5.2 Spain Migraine Drugs Market, By Route of Administration 8.3.4.5.3 Spain Migraine Drugs Market, By Distribution Channel 8.3.4.6 Rest of Europe 8.3.4.6.1 Rest of Europe Migraine Drugs Market, By Type 8.3.4.6.1.1. Rest of Europe Abortive Medicines Market, By Type 8.3.4.6.1.2. Rest of Europe Preventive Medicines Market, By Type 8.3.4.6.2 Rest of Europe Migraine Drugs Market, By Route of Administration 8.3.4.6.3 Rest of Europe Migraine Drugs Market, By Distribution Channel 8.4. ASIA-PACIFIC 8.4.1 ASIA-PACIFIC MIGRAINE DRUGS MARKET, BY TYPE 8.4.1.1 Asia-Pacific Abortive Medicines Market, By Type 8.4.1.2 Asia-Pacific Preventive Medicines Market, By Type 8.4.2 ASIA-PACIFIC MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION 8.4.3 ASIA-PACIFIC MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL 8.4.4 ASIA-PACIFIC MIGRAINE DRUGS, MARKET BY COUNTRY 8.4.4.1 China 8.4.4.1.1 China Migraine Drugs Market, By Type 8.4.4.1.1.1. China Abortive Medicines Market, By Type 8.4.4.1.1.2. China Preventive Medicines Market, By Type 8.4.4.1.2 China Migraine Drugs Market, By Route of Administration 8.4.4.1.3 China Migraine Drugs Market, By Distribution Channel 8.4.4.2 India 8.4.4.2.1 India Migraine Drugs Market, By Type 8.4.4.2.1.1. India Abortive Medicines Market, By Type 8.4.4.2.1.2. India Preventive Medicines Market, By Type 8.4.4.2.2 India Migraine Drugs Market, By Route of Administration 8.4.4.2.3 India Migraine Drugs Market, By Distribution Channel 8.4.4.3 Japan 8.4.4.3.1 Japan Migraine Drugs Market, By Type 8.4.4.3.1.1. Japan Abortive Medicines Market, By Type 8.4.4.3.1.2. Japan Preventive Medicines Market, By Type 8.4.4.3.2 Japan Migraine Drugs Market, By Route of Administration 8.4.4.3.3 Japan Migraine Drugs Market, By Distribution Channel 8.4.4.4 Australia 8.4.4.4.1 Australia Migraine Drugs Market, By Type 8.4.4.4.1.1. Australia Abortive Medicines Market, By Type 8.4.4.4.1.2. Australia Preventive Medicines Market, By Type 8.4.4.4.2 Australia Migraine Drugs Market, By Route of Administration 8.4.4.4.3 Australia Migraine Drugs Market, By Distribution Channel 8.4.4.5 South Korea 8.4.4.5.1 South Korea Migraine Drugs Market, By Type 8.4.4.5.1.1. South Korea Abortive Medicines Market, By Type 8.4.4.5.1.2. South Korea Preventive Medicines Market, By Type 8.4.4.5.2 South Korea Migraine Drugs Market, By Route of Administration 8.4.4.5.3 South Korea Migraine Drugs Market, By Distribution Channel 8.4.4.6 Rest of Asia-Pacific 8.4.4.6.1 Rest of Asia-Pacific Migraine Drugs Market, By Type 8.4.4.6.1.1. Rest of Asia-Pacific Abortive Medicines Market, By Type 8.4.4.6.1.2. Rest of Asia-Pacific Preventive Medicines Market, By Type 8.4.4.6.2 Rest of Asia-Pacific Migraine Drugs Market, By Route of Administration 8.4.4.6.3 Rest of Asia-Pacific Migraine Drugs Market, By Distribution Channel 8.5. REST OF WORLD 8.5.1 REST OF WORLD MIGRAINE DRUGS MARKET, BY TYPE 8.5.1.1 Rest of World Abortive Medicines Market, By Type 8.5.1.2 Rest of World Preventive Medicines Market, By Type 8.5.2 REST OF WORLD MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION 8.5.3 REST OF WORLD MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL 8.5.4 REST OF WORLD MIGRAINE DRUGS, MARKET BY COUNTRY 8.5.4.1 Brazil 8.5.4.1.1 Brazil Migraine Drugs Market, By Type 8.5.4.1.1.1. Brazil Abortive Medicines Market, By Type 8.5.4.1.1.2. Brazil Preventive Medicines Market, By Type 8.5.4.1.2 Brazil Migraine Drugs Market, By Route of Administration 8.5.4.1.3 Brazil Migraine Drugs Market, By Distribution Channel 8.5.4.2 South Africa 8.5.4.2.1 South Africa Migraine Drugs Market, By Type 8.5.4.2.1.1. South Africa Abortive Medicines Market, By Type 8.5.4.2.1.2. South Africa Preventive Medicines Market, By Type 8.5.4.2.2 South Africa Migraine Drugs Market, By Route of Administration 8.5.4.2.3 South Africa Migraine Drugs Market, By Distribution Channel 8.5.4.3 Saudi Arabia 8.5.4.3.1 Saudi Arabia Migraine Drugs Market, By Type 8.5.4.3.1.1. Saudi Arabia Abortive Medicines Market, By Type 8.5.4.3.1.2. Saudi Arabia Preventive Medicines Market, By Type 8.5.4.3.2 Saudi Arabia Migraine Drugs Market, By Route of Administration 8.5.4.3.3 Saudi Arabia Migraine Drugs Market, By Distribution Channel 8.5.4.4 Remaining Countries 8.5.4.4.1 Remaining Countries Migraine Drugs Market, By Type 8.5.4.4.1.1. Remaining Countries Abortive Medicines Market, By Type 8.5.4.4.1.2. Remaining Countries Preventive Medicines Market, By Type 8.5.4.4.2 Remaining Countries Migraine Drugs Market, By Route of Administration 8.5.4.4.3 Remaining Countries Migraine Drugs Market, By Distribution Channel 9. COMPANY PROFILES 9.1. ABBOTT LABORATORIES 9.1.1 COMPANY OVERVIEW 9.1.2 COMPANY SNAPSHOT 9.1.3 OPERATING BUSINESS SEGMENTS 9.1.4 PRODUCT PORTFOLIO 9.1.5 BUSINESS PERFORMANCE 9.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.2. ABBVIE INC. 9.2.1 COMPANY OVERVIEW 9.2.2 COMPANY SNAPSHOT 9.2.3 OPERATING BUSINESS SEGMENTS 9.2.4 PRODUCT PORTFOLIO 9.2.5 BUSINESS PERFORMANCE 9.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.3. ALLERGAN PLC. 9.3.1 COMPANY OVERVIEW 9.3.2 COMPANY SNAPSHOT 9.3.3 OPERATING BUSINESS SEGMENTS 9.3.4 PRODUCT PORTFOLIO 9.3.5 BUSINESS PERFORMANCE 9.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.4. ASTRAZENECA PLC 9.4.1 COMPANY OVERVIEW 9.4.2 COMPANY SNAPSHOT 9.4.3 OPERATING BUSINESS SEGMENTS 9.4.4 PRODUCT PORTFOLIO 9.4.5 BUSINESS PERFORMANCE 9.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.5. EISAI CO., LTD. 9.5.1 COMPANY OVERVIEW 9.5.2 COMPANY SNAPSHOT 9.5.3 OPERATING BUSINESS SEGMENTS 9.5.4 PRODUCT PORTFOLIO 9.5.5 BUSINESS PERFORMANCE 9.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.6. ENDO INTERNATIONAL PLC. 9.6.1 COMPANY OVERVIEW 9.6.2 COMPANY SNAPSHOT 9.6.3 OPERATING BUSINESS SEGMENTS 9.6.4 PRODUCT PORTFOLIO 9.6.5 BUSINESS PERFORMANCE 9.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.7. GLAXOSMITHKLINE PLC. 9.7.1 COMPANY OVERVIEW 9.7.2 COMPANY SNAPSHOT 9.7.3 OPERATING BUSINESS SEGMENTS 9.7.4 PRODUCT PORTFOLIO 9.7.5 BUSINESS PERFORMANCE 9.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.8. JOHNSON & JOHNSON 9.8.1 COMPANY OVERVIEW 9.8.2 COMPANY SNAPSHOT 9.8.3 OPERATING BUSINESS SEGMENTS 9.8.4 PRODUCT PORTFOLIO 9.8.5 BUSINESS PERFORMANCE 9.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.9. MERCK & CO., INC. 9.9.1 COMPANY OVERVIEW 9.9.2 COMPANY SNAPSHOT 9.9.3 OPERATING BUSINESS SEGMENTS 9.9.4 PRODUCT PORTFOLIO 9.9.5 BUSINESS PERFORMANCE 9.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.10. PFIZER INC. 9.10.1 COMPANY OVERVIEW 9.10.2 COMPANY SNAPSHOT 9.10.3 OPERATING BUSINESS SEGMENTS 9.10.4 PRODUCT PORTFOLIO 9.10.5 BUSINESS PERFORMANCE 9.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT